Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/10/25 17:23 | 10/9/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | S.d | -406 | 18.45 | 0 | -22 | -38 | 35 | D | ||||||||||||||
10/10/25 17:22 | 10/9/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | S.d | -117 | 18.23 | 0 | -6 | -4 | 145 | D | ||||||||||||||
10/8/25 17:33 | 10/6/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | S.dm | -553 | 18.21 | 0 | -30 | -17 | 145 | D | ||||||||||||||
10/8/25 17:33 | 10/6/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | S.dm | -912 | 18.06 | 0 | -51 | -20 | 203 | D | ||||||||||||||
10/1/25 16:57 | 9/29/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Meisner Lara | MA | O | GC | S.d | -499 | 14.75 | 0 | -34 | -100 | 0 | D | ||||||||||||||
9/17/25 17:01 | 9/15/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Meisner Lara | MA | O | GC | S.d | -182 | 11.49 | 0 | -16 | -100 | 0 | D | ||||||||||||||
6/18/25 17:12 | 6/16/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Meisner Lara | MA | O | GC | S.d | -165 | 10.43 | 0 | -16 | -100 | 0 | D | ||||||||||||||
3/18/25 18:35 | 3/14/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Meisner Lara | MA | O | GC | S.d | -1,021 | 12.90 | 0 | -79 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |